Interleukin 1β (IL-1β) is an important inflammatory mediator of type 2 diabetes. Here we show
that oligomers of islet amyloid polypeptide (IAPP), a protein that forms amyloid deposits in …

Obesity is associated with an increased risk of developing insulin resistance and type 2
diabetes. In obese individuals, adipose tissue releases increased amounts of non-esterified fatty …

Islet amyloid deposition is a pathogenic feature of type 2 diabetes, and these deposits contain
the unique amyloidogenic peptide islet amyloid polypeptide. Autopsy studies in humans …

The underlying pathophysiology of the metabolic syndrome is the subject of debate, with
both insulin resistance and obesity considered as important factors. We evaluated the …

Obesity is associated with insulin resistance, particularly when body fat has a central distribution.
However, insulin resistance also frequently occurs in apparently lean individuals. It has …

OBJECTIVE— We sought to determine whether a history of gestational diabetes mellitus (GDM)
further increases the risk of cardiovascular disease (CVD) in parous women with first-…

Amyloid deposition and reduced β-cell mass are pathological hallmarks of the pancreatic
islet in type 2 diabetes; however, whether the extent of amyloid deposition is associated with …

First-degree relatives of individuals with type 2 diabetes are at increased risk of developing
hyperglycemia. To examine the prevalence and pathogenesis of abnormal glucose …

Transgenic mice expressing the amyloidogenic human islet amyloid polypeptide (hIAPP) in
their islet β-cells are a model of islet amyloid formation as it occurs in type 2 diabetes. Our …

OBJECTIVE—The relative roles of insulin resistance and β-cell dysfunction in the
pathogenesis of impaired glucose tolerance (IGT) and type 2 diabetes are debated. First-degree …